Insider trading

Period: 12 months Stock: ADPT Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

88 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

88 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

88 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

88 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
88 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
88 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

88 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
26 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$269.13K 19,060 at 14.12
3.9%
Planned (10b5-1)
25 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$271.99K 19,060 at 14.27
3.9%
Planned (10b5-1)
24 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$261.12K 19,060 at 13.70
3.8%
Planned (10b5-1)
23 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$263.60K 19,060 at 13.83
3.8%
Planned (10b5-1)
20 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$254.83K 19,060 at 13.37
3.8%
Planned (10b5-1)
19 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$251.21K 19,060 at 13.18
3.7%
Planned (10b5-1)
18 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$251.21K 19,060 at 13.18
3.7%
Planned (10b5-1)
17 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$255.40K 19,060 at 13.40
3.7%
Planned (10b5-1)
16 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$255.59K 19,060 at 13.41
3.6%
Planned (10b5-1)
13 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$247.02K 19,060 at 12.96
3.6%
Planned (10b5-1)
12 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan 2×
$245.05K 19,060 at 12.86
3.6%
Planned (10b5-1)
11 Mar 2026
ROBINS HARLAN S Chief Scientific Officer
Sold at will 2×
$6.19M 470,266 at 13.17
23.6%
Not planned
11 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan 2×
$1.88M 141,583 at 13.29
21.5%
Planned (10b5-1)
11 Mar 2026
BENZENO SHARON Chief Commercial Ofc Imm Med
Sold at will
$831.07K 63,103 at 13.17
18.8%
Not planned
11 Mar 2026
BOBULSKY SUSAN Chief Commercial Officer, MRD
Sold at will
$544.42K 41,338 at 13.17
8.8%
Not planned
11 Mar 2026
LO FRANCIS Chief People Officer
Sold on a plan
$430.75K 30,593 at 14.08
9.5%
Planned (10b5-1)
10 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$285.67K 19,460 at 14.68
2.9%
Planned (10b5-1)
9 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$457.62K 30,941 at 14.79
4.6%
Planned (10b5-1)
6 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$468.45K 30,941 at 15.14
4.5%
Planned (10b5-1)
5 Mar 2026
LO FRANCIS Chief People Officer
Sold at will
$574.54K 38,074 at 15.09
10.6%
Not planned
5 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$495.06K 30,941 at 16.00
5.1%
Planned (10b5-1)
4 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$513.62K 30,941 at 16.60
5.1%
Planned (10b5-1)
3 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan 2×
$484.75K 30,941 at 15.67
5.0%
Planned (10b5-1)
3 Mar 2026
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$235.13K 14,233 at 16.52
1.2%
Planned (10b5-1)
2 Mar 2026
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$157.20K 10,000 at 15.72
0.8%
Planned (10b5-1)
3 Feb 2026
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$154.28K 8,120 at 19.00
0.7%
Planned (10b5-1)
2 Feb 2026
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$644.82K 34,668 at 18.60
2.8%
Planned (10b5-1)
12 Jan 2026
LO FRANCIS Chief People Officer
Sold on a plan
$1.41M 79,590 at 17.73
20.1%
Planned (10b5-1)
6 Jan 2026
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$164.40K 10,000 at 16.44
0.8%
Planned (10b5-1)
2 Jan 2026
LO FRANCIS Chief People Officer
Sold on a plan
$50.25K 3,125 at 16.08
1.0%
Planned (10b5-1)
22 Dec 2025
LO FRANCIS Chief People Officer
Sold on a plan
$76.90K 4,394 at 17.50
1.4%
Planned (10b5-1)
15 Dec 2025
LO FRANCIS Chief People Officer
Sold on a plan
$1.77M 113,890 at 15.57
26.5%
Planned (10b5-1)
4 Dec 2025
BENZENO SHARON Chief Commercial Ofc Imm Med
Sold on a plan
$212.38K 12,604 at 16.85
4.1%
Planned (10b5-1)
4 Dec 2025
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$166.10K 10,000 at 16.61
0.8%
Planned (10b5-1)
3 Dec 2025
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$506.42K 27,212 at 18.61
2.1%
Planned (10b5-1)
21 Nov 2025
BENZENO SHARON Chief Commercial Ofc Imm Med
Sold on a plan
$5.22M 308,477 at 16.91
51.0%
Sold half or more
20 Nov 2025
BENZENO SHARON Chief Commercial Ofc Imm Med
Sold on a plan
$4.93M 297,925 at 16.54
50.1%
Sold half or more
10 Nov 2025
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$148.20K 10,000 at 14.82
0.8%
Planned (10b5-1)
Showing 51–88 of 88. ← Newer Page 2 of 2